Aspirin: Tiger or pussy cat?

Ear, Nose and Throat Journal

Volumn 75, Issue 4, 1996, Pages 200-207

  Zinn, Willard J ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; PROSTACYCLIN; THROMBOXANE A2; VON WILLEBRAND FACTOR;

ACUTE HEART INFARCTION; ANOREXIA; ANTIINFLAMMATORY ACTIVITY; ATHEROSCLEROSIS; AUTOPSY; DRUG EFFICACY; DRUG INDICATION; HUMAN; NAUSEA; REVIEW; RHEUMATIC DISEASE; THROMBOSIS; TINNITUS; VOMITING;

EID: 0029935305     PISSN: 01455613     EISSN: None     Source Type: Journal    
DOI: 10.1177/014556139607500407     Document Type: Article

References (34)

1. Vane JR, Flower RJ, Botting RM. History of aspirin and its mechanism of action. Stroke 1990; 21(Suppl) IVS:12-23.
2. Silverman M. The fever fighters, in Magic in a Bottle. The Macmillan Co., 1948; 160-3.
3. Hanzlik PJ. Action and uses of the salicylates and cinchophen in medicine. Medicine 1926; 5:197-357
4. Smith JM, MacKinnon J. Etiology of aspirin bleeding. Lancet 1951; 2:569-70.
5. Douthwaite AH, Lintott GAM Gastroscopic observation of the effect of aspirin and certain other substances on the stomach. Lancet 1938; 21:1222-5.
6. Glasgow JFT, Moore R. Reye's syndrome - 30 years on. Possible marker of inherited metabolic disorders. Brit Med J 1993; 307:950-1.
7. Neivert H. Late secondary tonsillar hemorrhage. I. Studies of prothrombin and Vitamin K. Arch Otolaryngol 1945; 42:14-18.
8. Meyer OO, Howard B. Production of hypoprothrombinemia and hypocoagulation of the blood with salicylates. Proc Soc Biol & Med 1943, 53:234-7.
9. Gibson PC. Aspirin in the treatment of vascular diseases. Lancet 1949; 1172-4.
10. Craven LL. Experiences with aspirin (acetylsalicylic acid) in the nonspecific prophylaxis of coronary thrombosis. Mississippi Valley Med J 1953; 75:38-44.
11. Craven LL. Acetylsalicylic acid, possible preventive of coronary thrombosis. Ann Western Med & Surg 1950; 4:95-9.
12. Weiss HJ, Aledort LM. Impaired platelet-connective tissue reaction in man after aspirin ingestion. Lancet 1967; 2:495-7.
13. Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature New Biol 1971; 231:232-5.
14. Roth GI, Majerus PW. The mechanism of the effect of aspirin on human platelets: 1. Acetylation of a particulate fraction protein. J Clin Invest 1975; 56:624-32.
15. Moncada S, Vane JR. Arachidonic acid metabolites and the interactions between platelets and blood vessel walls. N Engl J Med 1979; 300:1142-7.
16. Roth GI, Calverley DC. Aspirin, platelets and thrombosis: Theory and practice. Blood 1994; 83:885-98.
17. Chesebro DH, et al. Antithrombotic therapy and progression of coronary artery disease. Antiplatelet vs. antithrombin. Circulation 1992; 86(Suppl III):100-11.
18. Szczeklik A. Thrombin generation in myocardial infarction and hypercholesterolemia. Thromb and Haemo 1995; 74:77-80.
19. Davis RF, Engleman EG. Incidence of myocardial infarction in patients with rheumatoid arthritis. Arthritis and Rheumatism 1974; 17:527-33.
20. Mickelson JK, et al. High dose intravenous aspirin, not low dose, intravenous or oral aspirin inhibits thrombus formation and stabilizes blood flow in experimental coronary vascular injury. JACC 1993; 21:502-10.
21. Fuster V, et al. Aspirin as a therapeutic agent in cardiovascular disease. Circ 1993; 87:659-75.
22. Moroz LA. Increased blood fibrinolytic activity after aspirin ingestion. N Engl J Med 1977; 296:525-9.
23. Dejana E. et al. "Aspirinated" platelets are haemostatic in thrombocytopenic rats with "non-aspirinated" vessel walls - Evidence from an exchange transfusion model. Blood 1980; 56 959-62.
24. Ratnatunga CP, et al. High dose aspirin inhibits shear-induced platelet reaction involving thrombin generation. Circ 1992; 83:1077-82.
25. Pareti FI, et al. Congenital deficiency of thromboxane and prostacyclin. Lancet 1980; 1:898-901.
26. Kelton JG, et al. Sex differences in the antithrombic effects of aspirin. Blood 1978; 52 1072-6.
27. Canadian Cooperative Study Group. A randomized trial of aspirin and sulfinpyrisone in threatened stroke. N Engl J Med 1978; 299:53-9
28. Harris WH, et al. Aspirin prophylaxis of venous thromboembolism after total hip replacement. N Engl J Med 1977; 297:1246-9.
29. Preston FE, et al. Inhibition of prostacyclin and platelet thromboxane A2 after low-dose aspirin. N Engl J Med 1981; 304:76-9.
30. Cairns JA, et al. Aspirin, sulfinpyrazone, or both in unstable angina. N Engl J Med 1985; 313:1369-75.
31. Helgason CM, et al Development of aspirin resistance in persons with previous ischemic stroke Stroke 1944; 25:2331-6.
32. Thun MJ, et al. Aspirin used and reduced risk of fatal colon cancer. N Engl J Med 1991; 325:1593-6.
33. Bornstein NM, et al. Failure of aspirin treatment after stroke. Stroke 1994; 25:275-7.
34. Siebert DJ, et al. Aspirin kinetics and platelet aggregation in man. Clin Pharmacol Therap 1983; 33.367-74.